Tenax Therapeutics (TENX) Institutional Ownership $4.67 -0.20 (-4.11%) (As of 09:17 AM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Tenax Therapeutics (NASDAQ:TENX)CurrentInstitutional OwnershipPercentage1.67%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$562.25KNumber ofInstitutional Sellers(last 12 months)0 Get TENX Insider Trade Alerts Want to know when executives and insiders are buying or selling Tenax Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TENX Institutional Buying and Selling by Quarter Ad DTIWhen it comes to NVDA… “acceleration cycles” are the keyExpert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away! Tenax Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024 Sphera Funds Management LTD.29,166$101K0.0%N/A0.855% 11/14/2024 Vestal Point Capital LP83,333$288K0.0%N/A2.444% 11/14/2024 Stonepine Capital Management LLC50,000$173K0.1%N/A1.466% 5/1/2023Virtu Financial LLC84,361$39K0.0%N/A0.377% 11/14/2022 Armistice Capital LLC1,965,885$334K0.0%+23.1%7.799% 11/5/2021 PNC Financial Services Group Inc.70,000$124K0.0%N/A0.278% 10/13/2021Gofen & Glossberg LLC IL3,819,170$6.76M0.2%N/A15.155% 8/16/2021 State Street Corp136,404$296K0.0%N/A0.911% 8/13/2021 Renaissance Technologies LLC192,232$400K0.0%-74.3%1.284% 8/13/2021 Northern Trust Corp34,671$72K0.0%+103.7%0.232% 8/13/2021 Vanguard Group Inc.356,347$742K0.0%+100.3%2.381% 8/12/2021 Dimensional Fund Advisors LP51,895$113K0.0%-14.1%0.347% 5/21/2021 Citadel Advisors LLC15,964$30K0.0%-41.4%0.107% 5/18/2021 Citadel Advisors LLC15,964$30K0.0%-41.4%0.107% 5/14/2021 Dimensional Fund Advisors LP60,412$115K0.0%N/A0.404% 5/13/2021 Renaissance Technologies LLC747,832$1.42M0.0%+75.1%4.996% 5/12/2021 Geode Capital Management LLC52,301$99K0.0%+58.5%0.349% 2/10/2021 Renaissance Technologies LLC427,032$794K0.0%-19.0%3.384% 12/11/2020Virtu Financial LLC21,564$33K0.0%-52.7%0.171% (Data available from 1/1/2016 forward) TENX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TENX shares? During the previous two years, the following institutional investors and hedge funds held shares of Tenax Therapeutics shares: Vestal Point Capital LP ($288K), Stonepine Capital Management LLC ($173K), and Sphera Funds Management LTD. ($101K), Virtu Financial LLC ($39K).Learn more on TENX's institutional investors. What percentage of Tenax Therapeutics stock is owned by institutional investors? 1.67% of Tenax Therapeutics stock is owned by institutional investors. Learn more on TENX's institutional investor holdings. Which institutional investors have been buying Tenax Therapeutics stock? The following institutional investors have purchased Tenax Therapeutics stock in the last 24 months: Virtu Financial LLC ($84.36K), Vestal Point Capital LP ($83.33K), Stonepine Capital Management LLC ($50K), and Sphera Funds Management LTD. ($29.17K). How much institutional buying is happening at Tenax Therapeutics? Institutional investors have bought a total of 246,860 shares in the last 24 months. This purchase volume represents approximately $3.70M in transactions. Related Companies Viveon Health Acquisition Major Shareholders Precision BioSciences Major Shareholders Prelude Therapeutics Major Shareholders Omega Therapeutics Major Shareholders AlloVir Major Shareholders InterCure Major Shareholders DBV Technologies Major Shareholders IO Biotech Major Shareholders RAPT Therapeutics Major Shareholders Shattuck Labs Major Shareholders This page (NASDAQ:TENX) was last updated on 11/18/2024 by MarketBeat.com Staff From Our PartnersJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purpose...Priority Gold | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Brownstone Research | Sponsored🗓️ My First LIVE Event in 5 Years!Give us 60 minutes and we’ll show you how we’ve compressed 15 years of stock market gains into one day.Behind the Markets | SponsoredTrump Win = "Bull Trap"?Dan's research shows that the last time the market looked this way, not only did our economy suffer a large su...Stansberry Research | SponsoredElon Musk’s $30 Billion Trump Bet Pays Off—What’s Next?Elon Musk bet big on Trump's victory, and that gamble has already added over $30 billion to his net worth in a...InvestorPlace | SponsoredNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | SponsoredBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...Golden Crest | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tenax Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tenax Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.